Geode Capital Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-463,689
| Closed | -$7.72M | – | 4072 |
|
|
2017
Q3 | $7.72M | Sell |
463,689
-6,829
| -1% | -$111K | ﹤0.01% | 1918 |
|
|
2017
Q2 | $8.42M | Sell |
470,518
-6,778
| -1% | -$127K | ﹤0.01% | 1776 |
|
|
2017
Q1 | $9.57M | Buy |
477,296
+70,999
| +17% | +$1.65M | ﹤0.01% | 1646 |
|
|
2016
Q4 | $10.2M | Buy |
406,297
+70,605
| +21% | +$1.67M | ﹤0.01% | 1559 |
|
|
2016
Q3 | $7.84M | Buy |
335,692
+10,990
| +3% | +$258K | ﹤0.01% | 1656 |
|
|
2016
Q2 | $6.49M | Sell |
324,702
-16,674
| -5% | -$311K | ﹤0.01% | 1733 |
|
|
2016
Q1 | $5.78K | Buy |
341,376
+14,161
| +4% | +$290K | ﹤0.01% | 1780 |
|
|
2015
Q4 | $7.26M | Sell |
327,215
-56,629
| -15% | -$1.18M | ﹤0.01% | 1599 |
|
|
2015
Q3 | $6.51M | Sell |
383,844
-49,321
| -11% | -$768K | ﹤0.01% | 1663 |
|
|
2015
Q2 | $5.96M | Sell |
433,165
-1,807
| -0.4% | -$24K | ﹤0.01% | 1783 |
|
|
2015
Q1 | $5.95M | Buy |
434,972
+45,658
| +12% | +$527K | ﹤0.01% | 1761 |
|
|
2014
Q4 | $4.11M | Buy |
389,314
+17,476
| +5% | +$207K | ﹤0.01% | 1929 |
|
|
2014
Q3 | $4.65M | Buy |
371,838
+136,647
| +58% | +$1.91M | ﹤0.01% | 1810 |
|
|
2014
Q2 | $3.22M | Sell |
235,191
-13,980
| -6% | -$183K | ﹤0.01% | 2084 |
|
|
2014
Q1 | $3.01M | Buy |
249,171
+30,466
| +14% | +$349K | ﹤0.01% | 2095 |
|
|
2013
Q4 | $2.69M | Buy |
218,705
+60,825
| +39% | +$714K | ﹤0.01% | 2112 |
|
|
2013
Q3 | $1.61M | Buy |
157,880
+29,095
| +23% | +$272K | ﹤0.01% | 2305 |
|
|
2013
Q2 | $1.16M | Buy |
+128,785
| New | +$1.3M | ﹤0.01% | 2387 |
|
Geode Capital Management's OME Position: Q4 2017 in Review
Geode Capital Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 463,689 shares — an estimated $7.72M sold.
Geode Capital Management first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $10.2M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Geode Capital Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Geode Capital Management sold 463,689 Omega Protein shares in Q4 2017, an estimated $7.72M.
- Geode Capital Management first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Geode Capital Management's Omega Protein position peaked at $10.2M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.